Publicação

Intensive Follow-Up After Curative Surgery for Colorectal Cancer

Ver documento

Detalhes bibliográficos
Resumo:Introduction: The purpose of postoperative surveillance programs after curative treatment for colorectal cancer is to detect asymptomatic recurrences with the premise that an important rate will be eligible for curative resection, improving overall survival. We have implemented a surveillance program for patients with colorectal cancer, stages II-III, with periodic clinical, carcinoembryonic antigen and cancer antigen-19-9 assessment, computed tomography and colonoscopy. The aim of this study was to assess the rate of curative treatment of recurrence, colorectal cancer mortality and clinical characteristics associated with non-resectable recurrence.Material and Methods: Open cohort study, single center. All patients on the intensive surveillance program between March 2008 and January 2015 were included. Statistics: chi-square, Wilcoxon rank sum test, logistic regression, Kaplan-Meier log-rank test (SPSS20®).Results: We had a total 404 patients evaluated; 59.6% male; mean age of 65 ± 10 years; 50.7% rectal tumor; 56.2% stage III. The average time of follow-up was 37 months and the recurrence rate was 12.9% (n = 52), mostly detected in the first three years (88.4%). The pattern of recurrence was associated with the site of the primary tumor (p < 0.001). Twenty-one patients underwent curative resection. Factors associated with non-resectable recurrence were aged ≥ 70 years (p = 0.022), disease location in the colon (p = 0.033) and cancer antigen-19-9-9 elevation (p = 0.024). The overall rate of cancer-specific mortality was 2.2% (n = 9).Discussion: The association between colon cancer and non-resectable recurrence is explained by the higher rate of disseminated disease in these patients. Cancer antigen-19-9 added no benefit to the surveillance program.Conclusion: This intensive real-world postoperative surveillance program allowed performing curative surgery to 40.3% of patients with recurrence.
Autores principais:Rodrigues, Rita Vale
Outros Autores:Silva, João Pereira da; Rosa, Isadora; Santos, Isabel; Pereira, Nuno; Soares, Carla; Pereira, António Dias
Assunto:cContinuity of Patient Care Colorectal Neoplasms/surgery Follow-Up Studies Survival Analysis Análise de Sobrevida Continuidade de Cuidados ao Doente Neoplasias Colorrectais/cirurgia Seguimento
Ano:2017
País:Portugal
Tipo de documento:artigo
Tipo de acesso:unknown
Instituição associada:Ordem dos Médicos
Idioma:inglês
Origem:Acta Médica Portuguesa
_version_ 1867503006139809792
author Rodrigues, Rita Vale
author2 Silva, João Pereira da
Rosa, Isadora
Santos, Isabel
Pereira, Nuno
Soares, Carla
Pereira, António Dias
author2_role author
author
author
author
author
author
author_facet Rodrigues, Rita Vale
Silva, João Pereira da
Rosa, Isadora
Santos, Isabel
Pereira, Nuno
Soares, Carla
Pereira, António Dias
author_role author
country_str PT
creators_json_txt [{\"Person.name\":\"Rodrigues, Rita Vale\"},{\"Person.name\":\"Silva, João Pereira da\"},{\"Person.name\":\"Rosa, Isadora\"},{\"Person.name\":\"Santos, Isabel\"},{\"Person.name\":\"Pereira, Nuno\"},{\"Person.name\":\"Soares, Carla\"},{\"Person.name\":\"Pereira, António Dias\"}]
datacite.creators.creator.creatorName.fl_str_mv Rodrigues, Rita Vale
Silva, João Pereira da
Rosa, Isadora
Santos, Isabel
Pereira, Nuno
Soares, Carla
Pereira, António Dias
datacite.rights.fl_str_mv http://purl.org/coar/access_right/c_abf2
datacite.subjects.subject.fl_str_mv cContinuity of Patient Care
Colorectal Neoplasms/surgery
Follow-Up Studies
Survival Analysis
Análise de Sobrevida
Continuidade de Cuidados ao Doente
Neoplasias Colorrectais/cirurgia
Seguimento
datacite.titles.title.fl_str_mv Intensive Follow-Up After Curative Surgery for Colorectal Cancer
Vigilância Intensiva do Carcinoma Colo-Rectal após Tratamento de Intenção Curativa
dc.creator.none.fl_str_mv Rodrigues, Rita Vale
Silva, João Pereira da
Rosa, Isadora
Santos, Isabel
Pereira, Nuno
Soares, Carla
Pereira, António Dias
dc.description.none.fl_str_mv Introdução: A vigilância intensiva pós-operatória do carcinoma colo-retal permite a deteção da recorrência em fase assintomática, aumentando o número de doentes que podem beneficiar de nova cirurgia. Implementámos um programa de vigilância de doentes com carcinoma colo-retal estádios II-III, operados com intenção curativa, com avaliação clínica, tomografia computorizada e colonoscopia. O presente estudo teve como objectivos avaliar a taxa de cirurgia de intenção curativa, a taxa de mortalidade por cancro e identificar características clínicas associadas à irresecabilidade da recidiva.Material e Métodos: Estudo de coorte, unicêntrico. Foram incluídos todos os doentes com carcinoma colo-retal integrados em programa de vigilância entre março de 2008 e janeiro de 2015. Análise estatística: qui-quadrado, Wilcoxon, regressão logística, Kaplan-Meier (SPSS20®).Resultados: Avaliámos 404 doentes; idade média: 65 ± 10 anos, 59,6% sexo masculino, 50,7% reto, 56,2% estádio III. O tempo médio de vigilância foi 37 meses e a taxa de recidiva foi 12,9% (n = 52), a maioria detetada nos primeiros três anos (88,4%). O padrão de recidiva associou-se à localização do tumor primário (p < 0,001). Vinte e um doentes foram submetidos a cirurgia curativa. Os fatores associados a recidiva irressecável foram: idade ≥ 70 anos (p = 0,022), carcinoma colo-retal localizado no cólon (p = 0,033) e elevação de antigénio carboidrato 19-9 (p = 0,024). A taxa global de mortalidade específica por cancro foi 2,2% (n = 9).Discussão: A associação entre neoplasia do cólon e recidiva irressecável deve-se à taxa mais elevada de doença disseminada nestes doentes. O antigénio carboidrato 19-9 não trouxe benefício acrescido ao programa de vigilância.Conclusão: Este estudo confirma o interesse clínico da vigilância intensiva na deteção de recidiva assintomática, permitindo alcançar cirurgia curativa em 40,3% dos doentes com recidiva.
dc.format.none.fl_str_mv application/pdf
image/jpeg
application/msword
application/msword
application/pdf
dc.identifier.none.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7889
dc.language.none.fl_str_mv eng
dc.publisher.none.fl_str_mv Ordem dos Médicos
dc.rights.none.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.source.none.fl_str_mv Acta Médica Portuguesa; Vol. 30 No. 9 (2017): September; 633-641
Acta Médica Portuguesa; Vol. 30 N.º 9 (2017): Setembro; 633-641
1646-0758
0870-399X
dc.subject.none.fl_str_mv cContinuity of Patient Care
Colorectal Neoplasms/surgery
Follow-Up Studies
Survival Analysis
Análise de Sobrevida
Continuidade de Cuidados ao Doente
Neoplasias Colorrectais/cirurgia
Seguimento
dc.title.fl_str_mv Intensive Follow-Up After Curative Surgery for Colorectal Cancer
Vigilância Intensiva do Carcinoma Colo-Rectal após Tratamento de Intenção Curativa
dc.type.none.fl_str_mv http://purl.org/coar/resource_type/c_6501
description Introduction: The purpose of postoperative surveillance programs after curative treatment for colorectal cancer is to detect asymptomatic recurrences with the premise that an important rate will be eligible for curative resection, improving overall survival. We have implemented a surveillance program for patients with colorectal cancer, stages II-III, with periodic clinical, carcinoembryonic antigen and cancer antigen-19-9 assessment, computed tomography and colonoscopy. The aim of this study was to assess the rate of curative treatment of recurrence, colorectal cancer mortality and clinical characteristics associated with non-resectable recurrence.Material and Methods: Open cohort study, single center. All patients on the intensive surveillance program between March 2008 and January 2015 were included. Statistics: chi-square, Wilcoxon rank sum test, logistic regression, Kaplan-Meier log-rank test (SPSS20®).Results: We had a total 404 patients evaluated; 59.6% male; mean age of 65 ± 10 years; 50.7% rectal tumor; 56.2% stage III. The average time of follow-up was 37 months and the recurrence rate was 12.9% (n = 52), mostly detected in the first three years (88.4%). The pattern of recurrence was associated with the site of the primary tumor (p < 0.001). Twenty-one patients underwent curative resection. Factors associated with non-resectable recurrence were aged ≥ 70 years (p = 0.022), disease location in the colon (p = 0.033) and cancer antigen-19-9-9 elevation (p = 0.024). The overall rate of cancer-specific mortality was 2.2% (n = 9).Discussion: The association between colon cancer and non-resectable recurrence is explained by the higher rate of disseminated disease in these patients. Cancer antigen-19-9 added no benefit to the surveillance program.Conclusion: This intensive real-world postoperative surveillance program allowed performing curative surgery to 40.3% of patients with recurrence.
dirty 0
eu_rights_str_mv unknown
format article
id amp_869a00d7d1e2cf98c8de98cd2dd6cbdd
identifier.url.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7889
instacron_str om
institution Ordem dos Médicos
instname_str Ordem dos Médicos
language eng
network_acronym_str amp
network_name_str Acta Médica Portuguesa
oai_identifier_str oai:ojs.www.actamedicaportuguesa.com:article/7889
organization_str_mv urn:organizationAcronym:om
person_str_mv Rodrigues, Rita Vale
Silva, João Pereira da
Rosa, Isadora
Santos, Isabel
Pereira, Nuno
Soares, Carla
Pereira, António Dias
publishDate 2017
publisher.none.fl_str_mv Ordem dos Médicos
reponame_str Acta Médica Portuguesa
repository_id_str urn:repositoryAcronym:amp
service_str_mv urn:repositoryAcronym:amp
spelling en-USIntensive Follow-Up After Curative Surgery for Colorectal Cancerpt-PTVigilância Intensiva do Carcinoma Colo-Rectal após Tratamento de Intenção CurativaRodrigues, Rita ValeSilva, João Pereira daRosa, IsadoraSantos, IsabelPereira, NunoSoares, CarlaPereira, António DiascContinuity of Patient CareColorectal Neoplasms/surgeryFollow-Up StudiesSurvival AnalysisAnálise de SobrevidaContinuidade de Cuidados ao DoenteNeoplasias Colorrectais/cirurgiaSeguimentoDireitos de Autor (c) 2017 Acta Médica Portuguesahttp://purl.org/coar/access_right/c_abf2https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7889URLhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7889URLHasVersionhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7889/5152URLHasVersionhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7889/8522URLHasVersionhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7889/9229URLHasVersionhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7889/9480URLHasVersionhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7889/9562URLHasVersion2017-09-29en-USIntroduction: The purpose of postoperative surveillance programs after curative treatment for colorectal cancer is to detect asymptomatic recurrences with the premise that an important rate will be eligible for curative resection, improving overall survival. We have implemented a surveillance program for patients with colorectal cancer, stages II-III, with periodic clinical, carcinoembryonic antigen and cancer antigen-19-9 assessment, computed tomography and colonoscopy. The aim of this study was to assess the rate of curative treatment of recurrence, colorectal cancer mortality and clinical characteristics associated with non-resectable recurrence.Material and Methods: Open cohort study, single center. All patients on the intensive surveillance program between March 2008 and January 2015 were included. Statistics: chi-square, Wilcoxon rank sum test, logistic regression, Kaplan-Meier log-rank test (SPSS20®).Results: We had a total 404 patients evaluated; 59.6% male; mean age of 65 ± 10 years; 50.7% rectal tumor; 56.2% stage III. The average time of follow-up was 37 months and the recurrence rate was 12.9% (n = 52), mostly detected in the first three years (88.4%). The pattern of recurrence was associated with the site of the primary tumor (p < 0.001). Twenty-one patients underwent curative resection. Factors associated with non-resectable recurrence were aged ≥ 70 years (p = 0.022), disease location in the colon (p = 0.033) and cancer antigen-19-9-9 elevation (p = 0.024). The overall rate of cancer-specific mortality was 2.2% (n = 9).Discussion: The association between colon cancer and non-resectable recurrence is explained by the higher rate of disseminated disease in these patients. Cancer antigen-19-9 added no benefit to the surveillance program.Conclusion: This intensive real-world postoperative surveillance program allowed performing curative surgery to 40.3% of patients with recurrence.pt-PTIntrodução: A vigilância intensiva pós-operatória do carcinoma colo-retal permite a deteção da recorrência em fase assintomática, aumentando o número de doentes que podem beneficiar de nova cirurgia. Implementámos um programa de vigilância de doentes com carcinoma colo-retal estádios II-III, operados com intenção curativa, com avaliação clínica, tomografia computorizada e colonoscopia. O presente estudo teve como objectivos avaliar a taxa de cirurgia de intenção curativa, a taxa de mortalidade por cancro e identificar características clínicas associadas à irresecabilidade da recidiva.Material e Métodos: Estudo de coorte, unicêntrico. Foram incluídos todos os doentes com carcinoma colo-retal integrados em programa de vigilância entre março de 2008 e janeiro de 2015. Análise estatística: qui-quadrado, Wilcoxon, regressão logística, Kaplan-Meier (SPSS20®).Resultados: Avaliámos 404 doentes; idade média: 65 ± 10 anos, 59,6% sexo masculino, 50,7% reto, 56,2% estádio III. O tempo médio de vigilância foi 37 meses e a taxa de recidiva foi 12,9% (n = 52), a maioria detetada nos primeiros três anos (88,4%). O padrão de recidiva associou-se à localização do tumor primário (p < 0,001). Vinte e um doentes foram submetidos a cirurgia curativa. Os fatores associados a recidiva irressecável foram: idade ≥ 70 anos (p = 0,022), carcinoma colo-retal localizado no cólon (p = 0,033) e elevação de antigénio carboidrato 19-9 (p = 0,024). A taxa global de mortalidade específica por cancro foi 2,2% (n = 9).Discussão: A associação entre neoplasia do cólon e recidiva irressecável deve-se à taxa mais elevada de doença disseminada nestes doentes. O antigénio carboidrato 19-9 não trouxe benefício acrescido ao programa de vigilância.Conclusão: Este estudo confirma o interesse clínico da vigilância intensiva na deteção de recidiva assintomática, permitindo alcançar cirurgia curativa em 40,3% dos doentes com recidiva.Ordem dos Médicosapplication/pdfimage/jpegapplication/mswordapplication/mswordapplication/pdfen-USActa Médica Portuguesa; Vol. 30 No. 9 (2017): September; 633-641pt-PTActa Médica Portuguesa; Vol. 30 N.º 9 (2017): Setembro; 633-6411646-07580870-399Xengjournal articlehttp://purl.org/coar/resource_type/c_6501literatureVoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85
spellingShingle Intensive Follow-Up After Curative Surgery for Colorectal Cancer
Rodrigues, Rita Vale
cContinuity of Patient Care
Colorectal Neoplasms/surgery
Follow-Up Studies
Survival Analysis
Análise de Sobrevida
Continuidade de Cuidados ao Doente
Neoplasias Colorrectais/cirurgia
Seguimento
status SINGLETON
status_str VoR
subject.fl_str_mv cContinuity of Patient Care
Colorectal Neoplasms/surgery
Follow-Up Studies
Survival Analysis
Análise de Sobrevida
Continuidade de Cuidados ao Doente
Neoplasias Colorrectais/cirurgia
Seguimento
title Intensive Follow-Up After Curative Surgery for Colorectal Cancer
title_full Intensive Follow-Up After Curative Surgery for Colorectal Cancer
title_fullStr Intensive Follow-Up After Curative Surgery for Colorectal Cancer
title_full_unstemmed Intensive Follow-Up After Curative Surgery for Colorectal Cancer
title_short Intensive Follow-Up After Curative Surgery for Colorectal Cancer
title_sort Intensive Follow-Up After Curative Surgery for Colorectal Cancer
topic cContinuity of Patient Care
Colorectal Neoplasms/surgery
Follow-Up Studies
Survival Analysis
Análise de Sobrevida
Continuidade de Cuidados ao Doente
Neoplasias Colorrectais/cirurgia
Seguimento
topic_facet cContinuity of Patient Care
Colorectal Neoplasms/surgery
Follow-Up Studies
Survival Analysis
Análise de Sobrevida
Continuidade de Cuidados ao Doente
Neoplasias Colorrectais/cirurgia
Seguimento
url https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7889
visible 1